Journal of Medical Microbiology 1991: Vol 35 Index

9 Pages·1991·0.42 MB·English

INDEX OF SUBJECTS FOR VOLUME 35
Abscess ofloxacin, interactions with coumermycin and
infection with E. coli and B.fragilis, 18 novobiocin, 358
Acquired Immune Deficiency Syndrome (AIDS) 4-quinoIones, interactions with gyrase subunit B
clinical and diagnostic analysis, 1 inhibitors, 358
with toxoplasmosis, 1 sulphonamide plus pyrimethamine, 1
Actinomyces susceptibility testing of mycoplasmas. 89
A. israelii, detection in genital tract susceptibility testing of X. maltophilia, 208
infections, 224 tetracycline, susceptibility testing of mycoplasmas, 89
A. israelii, and intra-uterine contraceptive devices, 224 Antibodies
in oral microflora, 5 against B. pertussis, 176
Adenovirus, 219 against hepatitis B virus, 291
Adenylate cyclase, of B. pertussis, 182 against H. influenzae, 139
Adherence against interferon, 29
of B. pertussis, 181 against S. typhimurium, 53
EPEC adherence factor, 270, 278 against T. gorulii, 1
H. influenzae, to human tissues, 129 see also Monoclonal antibodies
H. pylori, to gastric epithelial cells, 197 Antigens
S. marcescens, to bladder epithelial cells, 93 changes in specificities of C. coli, 168
Aerobactin of enterotoxigenic E. coli, 162
production by E. coli in urine, 324 HBe, of hepatitis B virus, 291
Aeromonas hydrophila of H. influenzae, 139
antimicrobial resistance, 264 polypeptide, of B.fragilis, 118
plasmids, 264 streptokinase, 60
virulence factors, 264 variation in C. albicans, 321
Agar bead model, 139 Antisera
Agglutinogens, of B. pertussis, 182,189 against antigens of C. coli, 168
Amino acids against B. hominis strains, 35
antagonism of S. typhimurium, 111 Aspergillus fumigatus
sequence of B. pertussis toxin, 178 characterisation of alkaline protease, 23
sequence in dihydrofolate reductase type VI gene, 214 ATP bioluminescence, 89
Amoxycillin
susceptibility of H. influenzae, 139
Ampicillin resistance, of A. hydrophila, 264 Bacteroides
Anaerobes B.fragilis, antigenic composition, 118
faecal flora in inflammatory bowel disease, 238 B.fragilis, capsule, 229
gram-negative, selective medium, 294 B.fragilis in inflammatory bowel disease, 238
see also Bacteroides B.fragilis in intra-abdominal infection, 18
Antibiotic resistance B.fragilis in mixed infections with E. coli, 18
ampicillin, and A. hydrophila, 264 B.fragilis monoclonal antibodies, 229
carbapenem, and X. maltophilia, 208 B.fragilis polysaccharide expression, 229
cephalosporins, and X. maltophilia, 208 B. gracilis in periodontal infection, 294
cephalothiny^nd A. hydrophila, 208 B. gracilis selective medium, 294
expression of )?-lactamaMs by X. maltophilia, 208 B. ureolyticus (NTU) medium, 294
gentamicin, and A. hydrophila, 264 B. vulgatus in inflammatory bowel disease, 238
gentamicin, and S. aureus, 80 Benzyl penicillin resistance, of S. aureus, 72
kanamycin, and A. hydrophila, 264 Bifidobacteria, in inflammatory bowel disease, 238
kanamycin, and S. aureus, 72 Biochemical typing schemes
methicillin, and S. aureus, 80 identification of viridans streptococci, 367
multiresistance of A. hydrophila, 264 phenotyping of E. coli, 270
multiresistance of S. aureus, 72 profiles of group G streptococci, 148
neomycin, and A. hydrophila, 264 Bioluminescence assay, 89
neomycin, and S. aureus, 72 Blastocystis hominis
penicillin, and S. aureus, 72 immunological analysis of strains, 35
penicillin, and X. maltophilia, 208 BOOKS RECEIVED
prystanamycin, and A. hydrophila, 264 Alcohol, immunomodulation and AIDS (edited by D.
tetracycline, and A. hydrophila, 264 Seminara, R. R. Watson and A. Paulowski), 191
tetracycline, and S. aureus, 72 Bailey and Scott’s diagnostic microbiology, 8th edition
tobramycin, and A. hydrophila, 264 (Ellen Jo Baron and S. M. Finegold), 125
trimethoprim, and 5. aureus, 72 Basic human immunology (edited by D. P. Stites and A.
Antibiotics and other antimicrobial substances I. Terr), 309
amoxycillin, susceptibility of H. influenzae, 139 Chlamydial infections (edited by W. R. Bowie et al.), 309
cefixime in selective medium for E. coli, 107 Infection (by R. G. Finch and P. Ball), 375
ciprofloxacin, interactions with coumermycin and Modem pathology of AIDS and other retroviral
novobiocin, 358 infections. Application of contemporary methods
ciprofloxacin, susceptibility of mycoplasmas, 89 (edited by P. Racz, A. T. Haase and J. C.
coumermycin, interactions with ^quinolones, 358 Gluckman), 191
erythromycin, susceptibility of mycoplasmas, 89 Papillomaviruses (edited by P. M. Howley and T. R.
novobiocin, interactions with 4-quinolones, 358 Broker), 192
377
378 INDEX OF SUBJECTS
Pathogenesis of wound and biomaterial-associated Chlamydia
infections (edited by T. Wadstrom et ai), 191 C. pneumoniae, diagnosis by Chlamydia Spot-IF test, 244
Q fever. Volume I. The disease (edited by T. J. Marrie), C. trachomatis, diagnosis by Chlamydia Spot-IF test, 244
125 C. trachomatis, DNA probe assay, 159
Recent advances in mycoplasmology (edited by G. C. trachomatis in genital tract infections, 159
Stanek ef a/.), 125 Ciprofloxacin
Skin Langerhans (dendric) cells in viral infections and interactions with gyrase subunit B inhibitors, 358
AIDS (edited by Y. Becker), 256 susceptibility of mycoplasmas, 89
Staphylococci (edited by Dorothy Jones, R. G. Board Clostridium difficile, toxin B, 40
and M. Sussman), 309 Colonisation f^actor antigens, 162
Textbook of human virology (edited by R. B. Belshe), Complement
309 fixation, automation of tests, 249
Textbook of medical parasitology (by R. opsonisation, complement-dependent, 65
Panjarathinam), 309 Computer-assisted numerical analysis, 297
Topley and Wilson’s Principles of Bacteriology, Virology Continuous flow cultures, 111
and Immunity, 8th edition (edited by M. T. Parker, Copro-antibodies, 53
L. Collier et ai), 375 Coumermycin
Viral hepatitis: biological and clinical features, specific interactions with 4-quinolones, 358
diagnosis and prophylaxis. 2nd edition (by F. B. Crohn’s disease, 238
Hollingere/fl/.), 126 Cytotoxicity, of C. difficile toxin B, 40
Bordetella pertussis Cytotoxins
adenylate cyclase, 182 tracheal, of B. pertussis, 184
adhesion, 181
agglutinogens, 182,189 Densitometry, scanning, 297
antibodies, 176 Desferrioxamine
antigens, 175 susceptibility of S. epidermidis, 45
aroA mutant strains, 186 Diabetes
central nervous system effects of vaccine, 188 S. marcescens in urinary tract infections, 93
diagnosis of infection, 188 Diarrhoea
filamentous haemagglutinin, 176 enteropathogenic E. coli in children, 270
fimbriae, 181 infantile, and enterotoxigenic E. coli, 162
immune response, 175 Dihydrofolate reductase type VI
lipopolysaccharide endotoxins, 182 nucleotide sequence, 214
monoclonal antibodies, 176 DNA
pertussis toxin, 175 concentration of hepatitis B virus DNA, 291
pharmacological assay of pertussis toxin, 180 gene amplification, 98
recent developments in research, 174 gyrase, subunit B inhibitors, 358
role of iron in infection, 174 hybridisation, 80,98, 152,214,291
surveillance of serotypes, 189 probes, 80,98,152, 159,188
tetanus toxoid potency, and vaccines, 187 polymerase chain reaction, 1,98,188,284
tracheal cytotoxin, 184 restriction analysis, 80, 132, 168, 214,297
vaccines, 176
Borrelia burgdorferi Electronmicroscopy
detection in cerebrospinal fluid, 98 adherence of H. pylori, 197
in neuroborreliosis, 98 immuno-electronmicroscopy, 229
immuno-gold, 65
polysaccharide expression by B.fragilis, 229
Cadmium resistance of S. aureus, 72 scanning, 197, 338
Campylobacter coli surface proteins of coagulase-negative staphylococci, 65
antigenic shifts in serotype determinants, 168 test-tube brush formation by E. yurii, 338
Caruiida albicans transmission, 197, 338
monoclonal antibodies, 321 ELISA, automated sample processor, 249
morphology index, 321 Endotoxins, of B. pertussis, 182
Capsule, of B.fragilis, 229 Enterochelin, production by E. coli in urine, 324
Carbapenem resistance, of X. maltophilia, 208 Enterotoxins, of E. coli, 162
Carbapenemase activity, 208 Epidemiology
Carbohydrates biochemical phenotyping of enteropathogenic E. coli,
antagonism of 5. typhimurium, 111 270
Cats ribotyping of L. pneumophila, 152
group G streptococcal isolates, 148 typing of S. pyogenes, 304
Cefixime, in selective medium for E. coli, 107 Erythromycin, susceptibility of mycoplasmas, 89
Cell culture Escherichia coli
isolation of C. trachorrmtis, 159 biochemical phenotyping, 270
invasion of HEp-2 cells by S. typhimurium, 349 contact-haemolysin production, 330
Cephalosporin resistance, of X. maltophilia, 208 dihydrofolate reductase, 214
Cephalosporinase, 208 enteroaggregative, 278
Cephalothin resistance, oi A. hydrophila, 264 enteroinvasive (EIEC), 330
Cerebrospinal fluid (CSF) enteropathogenic (EPEC), 270,278
detection of B. burgdorferi, 98 enterotoxigenic (ETEC), 162
Cervical smears, 224 EPEC adherence factor, 270,278
Chemiluminescence, 65 epidemiology, 270
INDEX OF SUBJECTS 379
in infantile diarrhoea, 162 Hepatitis B virus
in inflammatory bowel disease, 238 concentration of DNA, 291
in intra-abdominal infections, 18 HBe antigen, 291
mannose-resistant haemagglutinin, 278 Histamine production, 363
in mixed infection with B.fragilis, 18 Histidine decarboxylase
phagocytosis and killing, 12,18 from respiratory tract isolates, 363
plasmid, 330 Histoplasma capsulatum
pre-opsonisation, 12 killing by macrophages, 29
siderophore production, 324 Hybridisation of DNA
sorbitol-MacConkey selective medium, 107 detection of B. burgdorferi in CSF, 98
in urinary tract infections 324 hepatitis B virus, 291
verotoxigenic, 107 sequencing of dihydrofolate reductase gene, 214
virulence factors, 270,278, 324,330 typing of L. pneumophila, 152
Eubacterium yurii subsp. yurii typing of S. aureus, 80
test-tube brush formation, 338
Faecal bacteria Imipenem resistance, of X. maltophilia, 208
antagonism of S. typhimurium, 111 Immune response, to B. pertussis infection, 175
enterotoxigenic £. coli, 162 Immunisation
in inflammatory bowel disease, 238 mice against B. pertussis, 176
semi-quantitative assessment technique, 238 mice against streptokinase, 60
Fibrin clot model, 18 mice against S. typhimurium, 53
Fimbriae Immunoblotting
of B. pertussis, 181 antibodies to H. influenzae, 139
of H. influenzae, 129 antigens of B.fragilis, 118
Flow cytometric analysis, 229 antigens of C. coli, 168
Fluorescence actin-staining test, 278 polysaccharide expression by B.fragilis, 229
Fluorogenic substrates, and streptococci, 367 surface proteins of coagulase-negative staphylococci, 65
Formate-fumarate dependent bacteria, 294 urine, in P. mirabilis infection, 203
Freeze-fracture technique, 338 Immunodiffusion, of B. hominis strains, 35
Immunofluorescence, 219,224,229,244, 321
Gardnerella vaginalis, in bacterial vaginosis, 103 Immunoglobulins
Gastric epithelial cells IgA, against S. typhimurium, 53
adherence of H. pylori, 197 IgG, in chronic H. influenzae infection, 139
IgG, against coagulase-negative staphylococci, 65
Gastritis, of pigs
spiral bacterium in, 345 P. mirabilis IgA protease, 203
"’Gastrospirillum suis” Immuno-gold labelling, 65
Immunoperoxidase staining, 129
in p>orcine gastric mucosa, 345
in porcine gastritis, 345 Inflammatory bowel disease
Gene ampliflcation, 98 assessment of faecal flora, 238
Genital tract infection Influenza viruses A and B, 219
detection of C. trachomatis, 159 Interferon, activation of macrophages, 29
diagnosis of A. hydrophila infection, 224 Intestinal infection, by Y. enterocolitica, 257
diagnosis of bacterial vaginosis, 103 Intra-abdominal infection
with intra-uterine contraceptive devices, 224 with B.fragilis and E. coli, 18
Gentamicin resistance Intra-uterine contraceptive devices, 224
of A. hydrophila, 264 Iron
of S. aureus, 80 desferrioxamine, in identification of streptococci, 45
Glomerulonephritis, post-streptococcal, 60 role in A. hydrophila infection, 264
Gram’s stain role in B. pertussis infection, 174
diagnosis of bacterial vaginosis, 103 siderophore production by E. coli, 324
test-tube brush formation by E. yurii, 338
Haemagglutinin, filamentous, of B. pertussis, 176
Haemagglutination, mannose-resistant, 278 Kanamycin resistance
Haemolytic activity of A. hydrophila, 264
of A. hydrophila, 264 of S. aureus, 72
contact-haemolysin production by E. coli, 330 Kemble star 700 sample processor, 249
contact-haemolysin production by shigellae, 330
of enteropathogenic E. coli, 270
Haemophilus /^-Lactamases
H. influenzae, adherence to human tissues, 129 expression by X. nmltophilia, 208
H. influenzae, fimbriae, 129 Lactobacilli
H. influenzae, histidine decarboxylase production, 363 in bacterial vaginosis, 103
H. influenzae, identification from sputum cultures, 49 in inflammatory bowel disease, 238
H. influenzae, model of chronic lung infection, 139 in oral microflora, 5
H. influenzae, rapid enzyme tests, 49 Legionella pneumophila
H. parainfluenzae, histidine decarboxylase production, restriction fragment length polymorphism typing, 152
363 Lipo-oligosaccharide antigens, of H. influenzae, 139
Haemstrip, 49 Liposaccharide (LPS)
Helicobacter pylori of B. pertussis, 182
adherence to gastric epithelial cells, 197 changes in specificity in C. coli, 168
HEp-2 cells, invasiveness of S. typhimurium, 349 chlamydial, monoclonal antibody against, 244
380 INDEX OF SUBJECTS
Listeria spp. of H. influenzae, 139
rapid identification by Rosco system, 193 of Y. enterocolitica, 257
Lung lavage fluid, 139
Lyme disease, 98 PACE 2, DNA probe assay, 152
Parainfluenza virus, 219
Penicillin resistance
Macrophages
of S. aureus, 72
interferon-activated, 29
of X. maltophilia, 208
killing of H. capsulatum, 29
Peptidoglycan, B. pertussis cell wall, 184
in mixed infections of E. coli and B.fragilis, 18
Periodontal disease, 294
Mannose-resistant haemagglutination, 278
Phagocytosis
Measles virus, 219
E. coli by polymorphonuclear leucocytes, 12
Media
S. epidermidis by monocytes, 65
B. ureolyticus (NTU), 294
S. epidermidis by polymorphonuclear leucocytes, 65
for contact-haemolysin production, 330
Pigs
in continuous flow culture, 111
“Gastrospirillum suis" in gastric mucosa, 345
nutrients, antagonism of 5. typhimurium, 111
Plaque
selective, for B. gracilis, 294
age-related changes in microflora, 5
selective for formate-fumarate dependent bacteria, 294
formate-fumerate dependent isolates, 294
selective for verotoxigenic E. coli, 107
Plasmids
Meningitis, 297
expression of proteins by Y. enterocolitica, 257
Meropenem resistance, of X. maltophilia, 208
of multi-resistant S. aureus, 72
Methicillin resistance, of 5. aureus, 80
probes, in typing of S. aureus, 80
Micro-immunofluorescence, 244
transfer, 72
Monoclonal antibodies
virulence of A. hydrophila, 264
against B.fragilis, 229
virulence of E. coli, 330
against C. albicans, 321
virulence of shigellae, 330
against chlamydial lipopolysaccharide, 244
Polyethylene glycol precipitation, 291
against coagulase-negative staphylococci, 65
Polymerase chain reaction (PCR), 1,98, 188,284
against fimbriae of H. influenzae, 129
Polymorphonuclear leucocytes (PMNLs)
against nephritis strain-associated streptokinase, 60
chemiluminescence, 65
against peritoneal macrophages, 18
phagocytosis and killing of E. coli, 12
against pertussis toxin, 176
phagocytosis of S. epidermidis, 65
Monocytes
role in intra-abdominal infection with E. coli and B.
activation by interferon, 29
fragilis, 18
phagocytosis of S. epidermidis, 65
Polysaccharide, expression by B.fragilis, 229
Moraxella (Branhamella) catarrhalis
PROCEEDINGS OF THE PATHOLOGICAL
production of histidine decarboxylase, 363
SOCIETY OF GREAT BRITAIN AND
Mouse model
IRELAND, Vol. 35 No. 5 November 1991. pp i-ix
diabetic, 93
Protease
intestinal infection with Y. enterocolitica, 257
alkaline, of A.fumigatus, 23
passive immunity against S. typhimurium, 53
P. mirabilis IgA protease, 203
renal pathogenicity of E. coli, 324
Proteins
S. marcescens in urinary tract infections, 93
in B. pertussis infections, 185
Mycobacterium leprae
in B. pertussis vaccines, 186
identification by polymerase chain reaction, 284
plasmid-mediated, of Y. enterocolitica, 257
ribosomal RNA, 284
polypeptide antigens of B.fragilis, 118
Mycoplasmas
surface, of coagulase-negative staphylococci, 65
antimicrobial sensitivity testing, 89
synthetic peptides, from B. pertussis toxin, 178
ATP bioluminescence, 89
see also Outer-membrane proteins
Prystanamycin resistance, of A. hydrophila, 264
Neomycin resistance Pseudomonas aeruginosa
of A. hydrophila, 264 production of histidine decarboxylase, 363
of S. aureus, 72 Proteus mirabilis
Neuroborreliosis, 98 dihydrofolate reductase, 214
Novibiocin, interactions with 4-quinolones, 358 IgA protease, 203
in urinary tract infections, 203
Obituary: Brendan Moore, 123 Pulmonary disease, chronic obstructive, 139
Ofloxacin Pyelonephritis, mouse model, 324
interactions with gyrase subunit B inhibitors, 358 Pyridoxal phosphate, 363
Opsonisation Pyrolysis mass spectrometry, 304
complement-dependent, 65
of E. coli, 12 4-Quinolones
of S. epidermidis, 65 interactions with gyrase subunit B inhibitors, 358
Oral bacteria
age-related microbiological changes, 5 Radiolabelling, of H. pylori, 197
selective medium for B. gracilis, 294 Rat model
selective medium for formate-fumarate dependent chronic lung infection by H. influenzae, 139
bacterial, 294 fibrin clot model, 18
Outer-membrane proteins (OMPs) intra-abdominal infection with E. coli and B.fragilis, 18
of B. pertussis, 185 Respiratory syncytial virus, 219
INDEX OF SUBJECTS 381
Respiratory tract infections Streptococci
acute viral, in children, 219 analysis of chromosomal DNA, 297
identification of H. influenzae in sputum, 49 group B /3-haemolytic, 297
chronic obstructive pulmonary disease, 139 group G, biochemical properties, 148
histidine decarboxylase from isolates, 363 group G, from cats, 148
Restriction analysis monoclonal antibodies, 60
antigenic shifts in C. coli serostrains, 168 nephritis strain-associated streptokinase, 60
chromosomal DNA of group B f?-haemolytic in oral microflora, 5
streptococci, 297 S. pyogenes, typing system, 304
dihydrofolate reductase gene, 214 viridans, biochemic^ identification scheme, 367
typing of L. pneumophila, 152 Streptokinase
typing of S. aureus, 80 nephritis strain-associated, 60
Restriction fragment length polymorphism typing, of L. Streptomycin resistance, of S. aureus, 72
pneumophila, 152 Sulphonamide plus pyrimethamine, 1
Rhamnose, fermentation by E. coli, 107 Superoxide anion-dependent fungicidal mechanism, 29
RNA, in ribotyping
of L. pneumophila, 152 Tetanus toxoid potency potentiation by pertussis vaccine,
of M. leprae, 284 187
Rosco system, 193 Tetracycline
resistance of A. hydrophila, 264
Salmonella typhimurium resistance of S. aureus, 72
antagonism by faecal bacteria, 111 susceptibility of mycoplasmas, 89
invasion of HEp-2 cells, 349 T-lymphocytes, in B. pertussis infection, 175
passive secretory immune response, 53 Tobramycin resistance, of A. hydrophila, 264
role of nutrients in mixed culture, 111 Toxins
virulence, 349 of C. difficile, 40
SDS-PAGE pertussis, 175
analysis of B. hominis strains, 35 see also Cytotoxins; Endotoxins; Enterotoxins
antigens of B.fragilis, 118 Toxoplasma gondii, detection of, 1
dihydrofolate reductase, 214 Toxoplasmosis
Septicaemia, 297 associated with AIDS, 1
Serology clinical and diagnostic analysis, 1
analysis of B. hominis strains, 35 treatment of, 1
concentration of hepatitis B virus from serum, 291 Trimethoprim resistance, of S. aureus, 12
diagnosis by Chlamydia Spot-IF test, 244
diagnosis of toxoplasmosis, 1 Ulcerative colitis, 238
Kemble Star 700 sample processor, 249 Ultracentrifugation, 291
serodiagnosisofB.yragi/is, 118 Urinary tract infections
Serum, pre-opsonisation of E. coli, 12 S. marcescens, 93
Serratia marcescens E. coli, 324
adherence to bladder epithelial cells, 93 P. mirabilis, 203
pathogenesis in urinary tract infections, 93 Urine
Shadow casting, 338 pre-opsonisation of E. coli, 12
Shigellae siderophore production by E. coli, 324
contact-haemolysin production, 330
plasmids, 330
Vaccines, against B. pertussis, 176
Siderophore
Vaginosis, bacterial, 103
desferrioxamine, in identification of streptococci, 45
Verotoxin, of E. coli, 107, 270
production by E. coli in urine, 324
Virulence factors
role in A. hydrophila infection, 264
A.fumigatus, 23
Sorbitol-MacConkey agar, 107
A. hydrophila, 264
Spiral bacterium
B. fragilis, 229
“Gastrospirillum suis” in porcine gastric mucosa, 345
B. pertussis, 174
Spirochaetes
E. coli, 270,278,324,330
B. burgdorferi in cerebrospinal fluid, 98
shigellae, 330
in oral microflora, 5
S. typhimurium, 349
Sputum samples
Y. enterocolitica, 257
rapid identification of H. influenzae, 49
Staphylococci
Western blotting, 35,60
coagulase-negative, susceptibility to desferrioxamine, 45
Whooping cough see Bordetella pertussis
coagulase-negative, monoclonal antibodies, 65
in oral microflora, 5
S. aureus, methicillin-resistant, 80 Xanthomonas maltophilia
S. aureus, multi-resistant, 72 /3-lactamase expression, 208
S. aureus, plasmids, 72 susceptibility to antibiotics, 208
5. aureus, transfer of resistance determinants, 72 X-ray spectrometry, 338
S. aureus typing by DNA probes, 80
S. epidermidis, monoclonal antibodies, 65 Yeasts, in oral microflora, 5
5. epidermidis, surface proteins, 65 Yersinia enterocolitica
S. epidermidis, susceptibility to desferrioxamine, 45 expression of plasmid-mediated proteins, 257
INDEX OF AUTHORS FOR VOLUME 35
Abudu O O, see Rotimi, et al., 103 bacteria that colonise the human respiratory
Aguilera A, see Blancx) et al., 162 tract, 363
Akova M, Bonfiglio G, Livermore D M.
Susceptibility to /5-lactam antibiotics of mutant Dabirsiaghi Carolyn L, see Krywolap et al., 338
strains of Xanthomonas maltophilia with high- Dankert j, see Sterk et al., 129
and low level constitutive expression of LI and Davies R J, see Cundell et al., 363
L2 ^-lactamases, 208 De Graaf L, see Timmerman et al., 65
Albert M J, see Haider et al., 330 Dealler S F, Foweraker Juliet, Lawson Papeta,
Alkarmi T O, see Elhag and Alkarmi, 118 Fortune Susan. Provisional identification of
Alonso M P, see Blanco et al., 162 Haemophilus influenzae from sputum cultures
Amin 11, see Douce et al., 349 within 1 h by rapid enzyme tests, 49
Amphlett M, Smith D J, Warren R E. An Dermott Evelyn, see Lutton, et al., 229
assessment of the Kemble Star 700 sample Dev ALIA J L, see Cundell et al., 363
processor for the automation of complement Douce Gillian R, Amin 11, Stephen J. Invasion of
fixation and ELISA tests in a microbiology HEp2 cells by strains of Salmonella typhimurium
laboratory, 249 of different virulence in relation to
Aubert Sylvie, see Monzon-Moreno et al., 80 gastroenteritis, 349
Drumm B, see Hemalatha et al., 197
Banjo T O, see Rotimi et al., 103 Duerden B I, see Giaffer et al., 238
Barbosa A J A, see Mendes et al., 345
Barja j L, see Borrego et al., 264 El Solh Nevine, see Monzon-Moreno et al., 80
Beighton D, Hardie J M, Whiley R A. A scheme Elhag K M, Alkarmi T O. A study of the antigenic
for the identification of viridans streptococci, composition of the fragilis group of Bacteroides,
367 118
Besnier j M, see Timmerman et al., 65
Bishop P A, see Wade et al., 294 Fairclough L, see Cox et al., 284
Blanco J, Gonzalez E A, Blanco M, Garabal J I, Fernandez S, see Blanco et al., 162
Alonso M P, Fernandez S, Villanueva R, Fischlschweiger W, see Krywolap et al., 338
Aguilera A, Garcia M A, Torres J, Rey A, Fleer A, see Timmerman et al., 65
Jansen W H, Guinee PAM. Enterotoxigenic Fortune Susan, see Dealler et al., 49
Escherichia coli associated with infant diarrhoea Foweraker Juliet, see Dealler et al., 49
in Galicia, north-western Spain, 162 Frenk E, see Monod et al., 23
Blanco M, see Blanco et al., 162 Fujita K, see Nagano et al., 297
Bonfiglio G, see Akova et al., 208
Borrego J J, Morinigo M A, Martinez- Garabal J I, see Blanco et al., 162
Manzanares E, Bosca M, Castro Dolores, Garcia M A, see Blanco et al., 162
Barja J L, Toranzo Alicia E. Plasmid Gargan R A, Brumfitt W, Hamilton-Miller J M
associated virulence properties of environmental T. Pre-opsonisation of Escherichia coli induces
isolates of Aeromonas hydrophila, 264 resistance to neutrophil killing in serum and
Bosca M, see Borrego et al., 264 urine: relationship to growth phase, 12
Brown M R W, see Maciver et al., 139 Garland Suzanne M, see Lees et al., 159
Brumfitt W, see Gargan et al.,\l Garland Suzanne M, see Leslie and Garland, 224
Brummer E, Kurita N, Yoshida S, Nishimura Geelen-Van Den Broek L, see Sterk et al., 129
Kazuko, Miyaji M. Killing of Histoplasma Giaffer M H, Holdsworth C D, Duerden B I.
capsulatum by y-interferon-activated human The assessment of faecal ffora in patients with
monocyte-derived macrophages: evidence for a inffammatory bowel disease by a simplified
superoxide anion-dependent mechanism, 29 bacteriological technique, 238
Gonzalez E A, see Blanco et al., 162
Carvalho ACT, see Mendes et al., 345 Grubb W B, see Udo and Grubb, 72
Castro Dolores, see Borrego et al., 264 Guinee PAM, see Blanco et al., 162
Challacombe S j, see Percival et al., 5 Guthrie R K, see Reitmeyer et al., 148
Chapman P A, Siddons Christine A, Zadik P M,
Jewes Linda. An improved selective medium Haider Khaleda, Albert M J, Hossain A, Nahar
for the isolation of Escherichia coli 0157,107 S. Contact-haemolysin production by entero-
Chaturvedi U C, see Jain et al., 219 invasive Escherichia coli and shigellae, 330
Cheasty T, see Scotland et al., 278 Hamilton-Miller J M T, see Gargan et al.,\2
Colston, M J, see Cox et al., 284 Hanski C, see Naumann et al., 257
Corbel M J, Redhead K. Recent developments in Hardie J M, see Beighton et al., 367
pertussis research, 174 Harjai K, see Sharma et al., 324
Corbitt G, see Sanyal et al., 291 Harrison T G, see Saunders et al., 152
Cox R A, Kempsell K, Fairclough L, Colston M Hastings J G M, see Limb et al., 89
J. The 16S ribosomal RNA of Mycobacterium Haththotuwa a, see Saunders et al., 152
leprae contains a unique sequence which can be Hawkey P M, see Kerr et al., 193
used for identification by the polymerase chain Hemalatha S G, Drumm B, Sherman P. Adherence
reaction, 284 of Helicobacter pylori to human gastric epithelial
Crockard a D, see Lutton et al., 229 cells in vitro, 197
CUNDELL D R, DEVALIA J L, WiLKS M, TaBAQCHALI Hennessey J N, see Mills et al., 168
S, Davies R J. Histidine decarboxylase from Hindmarch j M, see Magee et al., 304
382
INDEX OF AUTHORS 383
Holdsworth C D, see Giaffer et al., 238 Maciver I, Silverman S H, Brown M R W,
Holliman R E. Clinical and diagnostic findings in 20 O’Reilly T. Rat model of chronic lung
patients with toxoplasmosis and the Acquired infections caused by non-typable Haemophilus
Immune Deficiency Syndrome, 1 influenzae, 139
Hopwood V, see Merson-Davies et al.. 321 Maclaren D M, see Verweu et al., 18
Hossain a, see Haider et al., 330 McNeill T A, see Lutton et al., 229
Houthoff H J, see Sterk et al., 129 Magee J T, Hindmarch J M, Nicol C D. Typing of
Howard B M A, see Lewin et al., 358 Streptococcus pyogenes by pyrolysis mass
spectrometry, 304
Jain A, Pande A, Misra P K, Mathur A, Mallinson H, see Mannion et al., 244
Chaturvedi U C. An Indian hospital study of Mannion P T, Mallinson H, Treharne J D.
viral causes of acute respiratory infection in Serological diagnosis with the Chlamydia Spot-
children, 219 IF test, 244
Jansen W H, see Blancx) et al., 162 Margaret Barbara S, see Krywolap et al., 338
Jewes Linda, see Chapman et al., 107 Marot-Leblond a, see Merson-Davies et al., 321
Johnston K H, see Ohkuni et al., 60 Marsh P D, see Percival et al., 5
Martinez-Manzanares E, see Borrego et al., 264
Katouli M, Kuhn I, Mollby R. Biochemical Mathur A, see Jain et al., 219
phenotypes of enteropathogenic Escherichia coli Mendes E N, Queiroz Dulciene M M, Rocha G A,
common to Iran and Sweden, 270 Nogueira Ana M M F, Carvalho ACT,
Kempsell K, see Cox et al., 284 Lage A P, Barbosa A J A. Histopathological
Kerr K G, Rotowa N A, Hawkey P M, Lacey R study of porcine gastric mucosa with and
W. Evaluation of the Rosco system for the without a spiral bacterium (''Gastrospirillttm
identification of Listeria species 193 suis"), 345
Kerr M A, see Senior et al., 203 Merson-Davies L A, Hopwood V, Robert R,
Koornhof H J, see Wylie and Koornhof, 214 Marot-Leblond A, Senet J-M, Odds F C.
Kruger W H, Pulz M. Detection of Borrelia Reaction of Candida albicans cells of different
burgdorferi in cerebrospinal fluid by the morphology index with monoclonal antibodies
polymerase chain reaction, 98 specific for the hyphal form, 321
Krywolap G N, Fischlschweiger W, Dabirsiaghi Mills S D, Kurjanczyk L A, Shames B, Hennessy
Carolyn L, Margaret Barbara S. Surface J N, Penner j L. Antigenic shifts in serotype
layers of EiAacterium yurii subsp. yurii and their determinants of Campylobacter coli are
possible role in test-tube brush formation and accompanied by changes in the chromosomal
iron acquisition, 338 DNA restriction endonuclease digestion pattern,
Kudesia G, see Sanyal et al., 291 168.
Kuhn I, see Katouli et al., 270 Misra P K, see Jain et al., 219
Kukoschke K G, Muller H E. SDS-PAGE and Mittal R, see Sharma et al., 324
immunological analysis of different axenic Miyaji M, see Brummer et al., 29
Blastocystis hominis strains, 35 Mollby R, see Katouli et al., 270
Kurita N, see Brummer et al., 29 Monod M, Togni G, Rahalison L, Frenk E.
Kurjanczyk L a, see Mills et al., 168 Isolation and characterisation of an extracellular
alkaline protease of Aspergillus fumigatus, 23
Monzon-Moreno C, Aubert Sylvie, Morvan
Lacey R W, see Kerr et al., 193
Anne, El Solh Nevine. Usefulness of three
Lage a P, see Mendes et al., 345 probes in typing isolates of methicillin-resistant
Larkin M J, see Lutton et al., 229
Staphylococcus aureus (MRSA), 80
Lawson Papeta, see Dealler et al., 49
Morinigo M a, see Borrego et al., 264
Lees M I, Newnan Diane M, Garland Suzanne
Morvan Anne, see Monzon-Moreno et al., 80
M. Comparison of a DNA probe assay with
Muller H E, see Kukoschke and MCller, 35
culture for the detection of Chlamydia
Murono K, see Nagano et al., 297
trachomatis, 159
Leslie D E, Garland Suzanne M. Comparison of Nagano N, see Nagano et al., 297
immunofluorescence and culture for the Nagano Yukiko, Nagano N, Takahashi S,
detection of Actinomyces israelii in wearers of Murono K, Fujita K, Taguchi F, Okuwaki Y.
intra-uterine devices, 224 Restriction endonuclease digest patterns of
Lewin C S, Howard B M A, Smith J T. 4-Quinolone chromosomal DNA from group B ^haemolytic
interactions with gyrase subunit B inhibitors, streptococci, 297
358 Nahar S, see Haider et al., 330
Limb D I, Wheat P F, Hastings J G M, Spencer R Namavar F, see Verweu et al., 18
C. Antimicrobial susceptibility testing of Naumann M, Hanski C, Riecken E O. Expression
mycoplasmas by ATP bioluminescence, 89 in vivo of additional plasmid-mediated proteins
Lindsay J A, Riley T V. Susceptibility to during intestinal infection with Yersinia
desferrioxamine: a new test for the identification enterocolitica serotype 08, 257
of Staphylococcus epidermidis, 45 Newnan Diane M, see Lees et al., 159
Livermore D M, see Akova, et al., 208 Nicol C D, see Magee et al, 304
Loomes L M, see Senior et al., 203 Nishimura Kazuko, see Brummer et al, 29
Lutton Deborah A, Patrick Sheila, Crockard A Nishino T, see Obana et al., 93
D, Stewart Linda D, Larkin M J, Dermott Nogueira Ana M M F, see Mendes et al, 345
Evelyn, McNeill T A. Flow cytometric
analysis of within-strain variation in Obana Y, Shibata K, Nishino T. Adherence of
polysaccharide expression by Bacteroides fragilis Serratia marcescens in the pathogenesis of
by use of murine monoclonal antibodies. 229 urinary tract infections in diabetic mice, 93
384 INDEX OF AUTHORS
Odds F C, see Merson-Davies et al., 321 SiDDONS Christine A, see Chapman et al, 107
Ohkuni H, Todome Yuko, Yoshimura K, Silverman S H, see Maciver et al, 139
Yamamoto T, Suzuki H, Yokomuro K, Slayne M a, see Wade et al, 294
Johnston K H, Zabriskie J B. Detection of Smith D J, see Amphlett et al, 249
nephritis strain-associated streptokinase by Smith H R, see Scotland et al, 278
monoclonal antibodies, 60 Smith J T, see Lewin et al, 358
Okuwaki Y, see Nagano et al., 297 Spencer R C, see Limb et al, 89
O’Reilly T, see Maciver et al., 139 Steele J H, see Reitmeyer et al, 148
Stephen J, see Douce et al, 349
Pande a, see Jain et al., 219 Sterk L M T, Van Alphen L, Geelen-Van Den
Penner J L, see Mills et al., 168 Broek L, Houthoff H J, Dankert J.
Percival R S, Challacombe S J, Marsh P D. Age- Differential binding of Haemophilus influenzae to
related microbiological changes in the salivary human tissues by fimbriae, 129
and plaque microflora of healthy adults, 5 Stewart Linda D, see Lutton et al, 229
PULZ M, see Kruger and Pulz, 98 Suzuki H, see Ohkuni et al, 60
Queiroz Dulciene M M, 5CC Mendes et al., 345 Tabaqchali S, see Cundell et al, 363
Taguchi F, see Nagano et al, 297
Rahalison L, see Monod et al., 23 Takahashi S, see Nagano et al, 297
Redhead K, see Corbel and Redhead, 174 Taylor A G, see Saunders et al, 152
Reitmeyer j C, Guthrie R K, Steele J H. Timmerman C P, Besnier J M, De Graaf L,
Biochemical properties of group G streptococci Torensma R, Verkley a J, Fleer A, Verhoef
isolated from cats and man, 148 J. Characterisation and functional aspects of
Rey a, see Blanco et al., 162 monoclonal antibodies specific for surface
Riecken E O, see Naumann et al., 257 proteins of coagulase-negative staphylococci, 65
Reily T V, see Lindsay and Riley, 45 Todome Yuko, see Ohkuni et al, 60
Robert R, see Merson-Davies et al., 321 Togni G, see Monod et al, 23
Rocha G A, see Mendes et al., 345 Toranzo Alicia E, see Borrego et al, 264
Rotimi V O, Yakubu Z, Abudu O O, Banjo T O. Torensma R, see Timmerman et al, 65
Direct Gram’s stain of vaginal discharge as a Torres J F. Purification and characterisation of
means of diagnosing bacterial vaginosis, 103 toxin B from a strain of Clostridium difficile that
Rotowa N a, see Kerr et al., 193 does not produce toxin A, 40
Rowe B, see Scotland et al., 278 Torres J, see Blanco et al, 162
Treharne j D, see Mannion et al, 244
Said B, see Scotland et al., 278
Sanyal D, Kudesia G, Corbitt G. Comparison of Udo E E, Grubb W B. Transfer of resistance
ultracentrifugation and polyethylene glycol determinants from a multi-resistant
precipitation for concentration of hepatitis B Staphylococcus aureus isolate, 72
virus (HBV) DNA for molecular hybridisation Ushijima T, Seto A. Selected faecal bacteria and
tests and the relationship of HBV-DNA to HBe nutrients essential for antagonism of Salmonella
antigen and anti-HBe status, 291 typhimurium in anaerobic continuous flow
Saunders N A, Harrison T G, Haththotuwa A, cultures. 111
Taylor A G. A comparison of probes for
restriction fragment length polymorphism Van Alphen L, see Sterk et al, 129
(RFLP) typing of Legionella pneumophila Verhoef J, see Timmerman et al, 65
serogroup 1 strains, 152 Verkley A J, see Timmerman et al, 65
Schieman D a, see Shope and Schiemann, 53 Verweij W R, Namavar F, Schouten W F,
Schouten W F, see Verweij et al., 18 Maclaren D M. Early events after intra¬
Scotland S M, Smith H R, Said B, Willshaw G A, abdominal infection with Bacteroides fragilis and
Cheasty T, Rowe B. Identification of Escherichia coli, 18
enteropathogenic Escherichia coli isolated in Villanueva R, see Blanco et al, 162
Britain as enteroaggregative or as members of a
subclass of attaching-and-effacing E. coli not Wade W G, Bishop P A, Slayne M A. Bacteroides
hybridising with the EPEC adherence-factor ureolyticus (NTU) medium for the selective
probe, 278 recovery of Bacteroides gracilis, 294
Senet J-M, see Merson-Davies et al., 321 Warren R E, see Amphlett et al, 249
Senior B W, Loomes L M, Kerr M A. The Wheat P F, see Limb et al, 89
production and activity in vivo of Proteus Whiley R a, see Beighton et al, 367
mirabilis IgA protease in infections of the Wilks M, see Cundell et al, 363
urinary tract, 203 Willshaw G A, see Scotland et al, 278
Seto a, see Ushijima and Seto, 107 Wylie B A, Koornhof H J. Nucleotide sequence of
Shames B, see Mills et al, 168 dihydrofolate reductase type VI, 214
Sharma S, Harjai K, Mittal R. Enhanced
siderophore production and mouse kidney Yakubu Z, see Rotimi et al, 103
pathogenicity in Escherichia coli grown in urine, YamamotoT, see Ohkuni et al, 60
324 Yokomuro K, see Ohkuni et al, 60
Sherman P, see Hemalatha et al, 197 Yoshida S, see Brummer et al, 29
Shibata K, see Obana et al, 93 Yoshimura K, see Ohkuni et al, 60
Shope S R, Schiemann D A. Passive secretory
immunity against Salmonella typhimurium Zabriskie J B, see Ohkuni et al, 60
demonstrated with foster mouse pups, 53 Zadik P M, see Chapman et al, 107